Gugnoni M, Kashyap M, Wary K, Ciarrocchi A
Mol Cancer. 2025; 24(1):38.
PMID: 39891197
PMC: 11783725.
DOI: 10.1186/s12943-025-02236-7.
Herrmannova A, Jelinek J, Pospisilova K, Kerenyi F, Vomastek T, Watt K
Elife. 2024; 13.
PMID: 39495207
PMC: 11534336.
DOI: 10.7554/eLife.95846.
Payea M, Dar S, Anerillas C, Martindale J, Belair C, Munk R
Mol Cell. 2024; 84(22):4454-4469.e7.
PMID: 39481386
PMC: 11585442.
DOI: 10.1016/j.molcel.2024.10.003.
Ong H, Yang X, Smith J, Taft-Benz S, Howell S, Dickmander R
Molecules. 2024; 29(17).
PMID: 39275006
PMC: 11397024.
DOI: 10.3390/molecules29174158.
Xiong S, Zhou J, Tan T, Chung T, Tan T, Toh S
Nat Commun. 2024; 15(1):6810.
PMID: 39122682
PMC: 11316114.
DOI: 10.1038/s41467-024-50910-z.
More than an Amide Bioisostere: Discovery of 1,2,4-Triazole-containing Pyrazolo[1,5-]pyrimidine Host CSNK2 Inhibitors for Combatting β-Coronavirus Replication.
Ong H, Yang X, Smith J, Dickmander R, Brown J, Havener T
J Med Chem. 2024; 67(14):12261-12313.
PMID: 38959455
PMC: 11284802.
DOI: 10.1021/acs.jmedchem.4c00962.
Overexpression of carbonyl reductase 1 in ovarian cancer cells suppresses proliferation and activates the eIF2 signaling pathway.
Kadonosawa Y, Yokoyama M, Tatara Y, Fujita T, Yokoyama Y
Oncol Lett. 2024; 28(2):359.
PMID: 38881711
PMC: 11177172.
DOI: 10.3892/ol.2024.14492.
Regulation of cancer progression by CK2: an emerging therapeutic target.
Hussain S, Guo Y, Huo Y, Shi J, Hou Y
Med Oncol. 2024; 41(5):94.
PMID: 38526625
DOI: 10.1007/s12032-024-02316-6.
Excitatory neuron-specific suppression of the integrated stress response contributes to autism-related phenotypes in fragile X syndrome.
Hooshmandi M, Sharma V, Perez C, Sood R, Krimbacher K, Wong C
Neuron. 2023; 111(19):3028-3040.e6.
PMID: 37473758
PMC: 10592416.
DOI: 10.1016/j.neuron.2023.06.017.
Surviving and Adapting to Stress: Translational Control and the Integrated Stress Response.
Wek R, Anthony T, Staschke K
Antioxid Redox Signal. 2023; 39(4-6):351-373.
PMID: 36943285
PMC: 10443206.
DOI: 10.1089/ars.2022.0123.
Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma.
Scagliola A, Miluzio A, Biffo S
Int J Mol Sci. 2023; 24(5).
PMID: 36902316
PMC: 10002961.
DOI: 10.3390/ijms24054885.
Cap-dependent translation initiation monitored in living cells.
Gandin V, English B, Freeman M, Leroux L, Preibisch S, Walpita D
Nat Commun. 2022; 13(1):6558.
PMID: 36323665
PMC: 9630388.
DOI: 10.1038/s41467-022-34052-8.
Ribosome changes reprogram translation for chemosurvival in G0 leukemic cells.
Datta C, Truesdell S, Wu K, Bukhari S, Ngue H, Buchanan B
Sci Adv. 2022; 8(43):eabo1304.
PMID: 36306353
PMC: 9616492.
DOI: 10.1126/sciadv.abo1304.
Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation.
Thus Y, de Rooij M, Swier N, Beijersbergen R, Guikema J, Kersten M
Haematologica. 2022; 108(3):797-810.
PMID: 36226498
PMC: 9973496.
DOI: 10.3324/haematol.2022.281668.
Phosphorylation of FAM134C by CK2 controls starvation-induced ER-phagy.
Di Lorenzo G, Iavarone F, Maddaluno M, Plata-Gomez A, Aureli S, Quezada Meza C
Sci Adv. 2022; 8(35):eabo1215.
PMID: 36044577
PMC: 9432840.
DOI: 10.1126/sciadv.abo1215.
CK2 and the Hallmarks of Cancer.
Firnau M, Brieger A
Biomedicines. 2022; 10(8).
PMID: 36009534
PMC: 9405757.
DOI: 10.3390/biomedicines10081987.
Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics.
Gyenis L, Menyhart D, Cruise E, Jurcic K, Roffey S, Chai D
Front Mol Biosci. 2022; 9:909711.
PMID: 35755813
PMC: 9225150.
DOI: 10.3389/fmolb.2022.909711.
pSNAP: Proteome-wide analysis of elongating nascent polypeptide chains.
Uchiyama J, Roy R, Wang D, Morikawa K, Kawahara Y, Iwasaki M
iScience. 2022; 25(7):104516.
PMID: 35754732
PMC: 9218386.
DOI: 10.1016/j.isci.2022.104516.
Extracellular vesicles rich in HAX1 promote angiogenesis by modulating ITGB6 translation.
You B, Pan S, Gu M, Zhang K, Xia T, Zhang S
J Extracell Vesicles. 2022; 11(5):e12221.
PMID: 35524442
PMC: 9077140.
DOI: 10.1002/jev2.12221.
Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells.
Uchenunu O, Zhdanov A, Hutton P, Jovanovic P, Wang Y, Andreev D
FEBS Open Bio. 2022; 12(5):959-982.
PMID: 35302710
PMC: 9063438.
DOI: 10.1002/2211-5463.13398.